• SENSEX 78,094.64
    166.49 (+0.21%)
  • BANKNIFTY 57,264.85
    117.35 (+0.21%)
  • Bajaj Finance
    1,151.20 1,151.20(%)
  • Torrent Pharma.
    5,139.30 5,139.30(%)
  • Netweb Technol.
    4,597.95 5,241.65(%)
  • TVS Motor Co.
    4,320.00 4,320.00(%)
  • Rossell Techsys
    979.95 1,111.00(%)
  • Indo-MIM
    815.90 815.90(%)
  • Kaynes Tech
    3,860.55 7,705.00(%)
  • Hero Motocorp
    5,397.80 6,390.00(%)
  • 63 Moons Tech.
    949.65 1,029.35(%)
  • Adani Ports
    1,707.00 1,891.80(%)
  • Shadowfax Technologies
    253.35 253.35(%)
  • Kalyan Jewellers
    610.15 327.15(%)
  • M & M
    3,456.00 3,840.00(%)
  • Tata Motors
    440.40 508.95(%)
  • HFCL
    194.30 229.40(%)
  • Hyundai Motor I
    2,208.90 2,889.65(%)
  • Swiggy
    280.00 235.85(%)
  • TBO Tek
    1,565.80 1,764.00(%)
  • Reliance Industries
    1,309.30 1,611.20(%)
  • Eicher Motors
    7,795.00 5,390.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vineet Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71715.0
  • ISIN : INE505Y01010
39.63 1 (1.98%)
  • As on 31 Jul 2026 (EOD)

  • Today’s Low

    38.88

  • Today’s High

    40.20

  • Open

    39.90

  • Perv Close

    38.86

  • 52W Low

    25.65

  • 52W High

    43.50

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    76.11

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.00

  • Debt-Equity Ratio

    1.98

  • AGM Date

    31-Jul-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    76.11

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    19.21

  • BV (₹)

    23.00

  • Sales( ₹ in Cr.)

    75.00

  • NP (in Cr.)

    -22.09

  • NP Var(%)

    -2904.0

  • Div%

    0.0

  • CPS (₹)

    -10.20

  • EPS (₹)

    -11.50

  • Traded Value (₹ in Lakhs)

    75.10

  • 52 Week High

    43.50

  • 52 Week Low

    25.65

  • Price BSE

    39.0

  • Price NSE

    40.00

  • Market Capital( in Cr.)

    75.10

  • P/C Ratio

    -3.80

  • P/E Ratio

    -3.40

  • Price Vs.BV

    -11.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 75.00 150.59 212.29 191.17 243.48 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 75.00 150.59 212.29 191.17 243.48 0.00
Other Income 1.99 0.46 0.12 0.29 0.39 0.00
Stock Adjustments -6.47 17.79 -4.23 5.85 -5.36 0.00
Total Income 70.52 168.84 208.18 197.31 238.51 0.00
EXPENDITURE :            
Raw Materials 63.77 131.70 168.10 151.40 192.76 0.00
Power and Fuel Cost 3.99 6.30 6.15 4.74 7.03 0.00
Employee Cost 5.34 6.38 6.00 4.91 5.57 0.00
Other Manufacturing Expenses 8.23 11.63 13.40 16.94 21.20 0.00
Selling and Administration Expenses 3.41 5.10 5.58 5.09 2.42 0.01
Miscellaneous Expenses 0.07 0.07 1.18 0.79 1.00 0.00
Employee Benefit Expenses 5.34 6.38 6.00 4.91 5.57 0.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 84.81 161.17 200.41 183.86 229.98 0.01
Operating Profit -14.29 7.66 7.78 13.45 8.54 -0.01
Interest 3.98 4.78 3.38 2.09 2.67 0.00
Gross Profit -18.27 2.88 4.40 11.36 5.87 -0.01
Depreciation 2.50 2.52 2.37 2.02 1.81 0.00
Profit Before Tax -20.77 0.36 2.03 9.34 4.06 -0.01
Current Tax 0.00 -0.06 0.56 3.18 1.28 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.58 -0.60 0.22 -0.48 1.00 0.00
Reported Net Profit -20.19 1.03 1.25 6.64 1.78 -0.01
Extraordinary Items 1.90 0.24 0.00 0.00 0.00 0.00
Adjusted Net Profit -22.09 0.79 1.25 6.64 1.78 -0.01
Adjustment below Net Profit 0.00 0.00 0.00 -0.04 0.22 0.00
P & L Balance brought forward 14.27 13.24 12.91 6.31 4.31 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.92 0.00 0.00 0.00
P & L Balance carried down -5.92 14.27 13.24 12.91 6.31 -0.01
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 10.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 1.00 0.00 0.00
Earnings Per Share-Unit Curr -21.90 1.11 1.36 7.20 1.93 -0.27
Earnings Per Share(Adj)-Unit Curr -18.40 0.93 1.14 6.05 - -
Book Value 15.89 37.67 36.54 36.03 28.87 9.73
Book Value(Adj)-Unit Curr 13.35 31.66 30.70 30.28 - -

Shareholding Pattern

  • Promoter Group

    5.98%

  • Public Share Holding

    94.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,149,097 5.98 1,149,097 14
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,149,097 5.98 1,149,097 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 68,999 0.36 68,999 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 68,999 0.36 68,999 1
2] Non Institution
Bodies Corporate 220,279 1.15 220,279 26
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 337,937 1.76 337,937 77
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 293,297 1.53 293,297 179
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 11,809,976 61.49 11,809,976 117
Individuals holding nominal share capital up to Rs. 1 lakh 5,232,867 27.25 5,232,867 9,513
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 17,988,170 93.66 17,988,170 9,914
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 19,206,266 100.00 19,206,266 9,929

Company Background

Vineet Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vineet Laboratories Ltd
  • BSE Code : 71715.0
  • ISIN : INE505Y01010

  • Incorporation Year

    2016

  • Registered Office

    SyNo 11/A3 Saheb Nagar KurduVi
    Chintal Kunta Eshwaramma LB Nr, Hyderabad,
    Telangana-500074

  • Telephone

    91-40-24128833

  • FAX

  • Chairman

    Dilip V Acharekar

  • Managing Director

  • Company Secretary

    Ramesh Kumar Bandari

  • Auditor

    NSVR & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Vineet Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vineet Laborator 39.10 76.98 75.00 -7.41 0.00
Abbott India 27,784.15 7,217.19 6,929.05 38.04 43.78
Astrazeneca Phar 8,103.65 2,304.07 2,275.58 108.03 27.86
P & G Health Ltd 6,597.45 944.52 934.17 33.50 71.75
Glaxosmi. Pharma 2,653.45 3,932.76 3,790.20 44.42 58.17
Cipla 1,472.95 20,102.60 18,979.95 38.71 13.88
Amrutanjan Healt 515.00 469.50 451.82 25.71 21.89
Fermenta Biotec. 501.25 474.15 450.25 22.95 18.77
Bliss GVS Pharma 467.40 773.53 729.81 51.25 12.51
Guj. Themis Bio. 358.85 152.47 150.80 83.84 27.21
Ambalal Sarabhai 34.87 19.52 3.94 24.38 6.77